In conclusion, for the first time, the present study revealed a novel regulatory mechanism that circVANGL1/miR-195/Bcl-2 axis regulates NSCLC progression, providing a new insight for the development of circRNA-directed diagnostics and therapeutics against this deadly malignancy. The gene discussed is BCL2; the disease is non-small cell lung carcinoma.